Form 8-K - Current report:
SEC Accession No. 0001193125-25-244275
Filing Date
2025-10-21
Accepted
2025-10-21 07:25:20
Documents
14
Period of Report
2025-10-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d637082d8k.htm   iXBRL 8-K 25478
2 EX-10.1 d637082dex101.htm EX-10.1 862554
6 GRAPHIC g637082g1016061854670.jpg GRAPHIC 53502
  Complete submission text file 0001193125-25-244275.txt   1253623

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA pstv-20251016.xsd EX-101.SCH 2877
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE pstv-20251016_lab.xml EX-101.LAB 17994
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pstv-20251016_pre.xml EX-101.PRE 11279
17 EXTRACTED XBRL INSTANCE DOCUMENT d637082d8k_htm.xml XML 3658
Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 737.255.7194
PLUS THERAPEUTICS, INC. (Filer) CIK: 0001095981 (see all company filings)

EIN.: 330827593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34375 | Film No.: 251405360
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)